UTRS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Minerva Surgical Insider Trading History Chart

Minerva Surgical Share Price & Price History

^$0.00

▼ -0.0001 (-100.00%)

As of 03/14/2025 01:00 AM ET

Days: 30 | 90 | 365

Minerva Surgical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/9/2023	Enterprise Associates 13 L New	Major Shareholder	Buy	1,221,896	$4.00	$4,887,584.00	1,721,852

SEC Filings (Institutional Ownership Changes) for Minerva Surgical (NASDAQ:UTRS)

Institutional Buying and Selling by Quarter

Minerva Surgical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/14/2023	AWM Investment Company Inc.	1,668,572	$0.37M	0.1%	+20.2%	5.595%
11/14/2022	Luminus Management LLC	998,663	$0.79M	0.3%	+46.5%	3.460%
10/24/2022	Lyell Wealth Management LP	58,710	$47K	0.0%	N/A	0.203%
8/15/2022	Luminus Management LLC	681,843	$1.60M	0.5%	+25.3%	2.363%
8/12/2022	AWM Investment Company Inc.	1,546,517	$3.63M	0.6%	+18.6%	5.363%
8/3/2022	Laird Norton Trust Company LLC	130,894	$0.31M	0.0%	N/A	0.454%
7/19/2022	Commonwealth Equity Services LLC	23,339	$54K	0.0%	N/A	0.081%
2/14/2022	Perceptive Advisors LLC	87,768	$0.45M	0.0%	N/A	0.305%
2/14/2022	Ghisallo Capital Management LLC	75,000	$0.39M	0.0%	N/A	0.260%
2/14/2022	Novo Holdings A S	2,057,132	$10.57M	0.5%	N/A	7.139%

Data available starting January 2016

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Today's Range

Now: N/A

50 Day Range

MA: $0.01

$0.00

$0.01

52 Week Range

Now: N/A

Volume

38 shs

Average Volume

1,325 shs

Market Capitalization

$1,000.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.92